Mandel, P.; Wenzel, M.; Hoeh, B.; Welte, M.N.; Preisser, F.; Inam, T.; Wittler, C.; Humke, C.; Köllermann, J.; Wild, P.;
et al. Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making. Curr. Oncol. 2021, 28, 2123-2133.
https://doi.org/10.3390/curroncol28030197
AMA Style
Mandel P, Wenzel M, Hoeh B, Welte MN, Preisser F, Inam T, Wittler C, Humke C, Köllermann J, Wild P,
et al. Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making. Current Oncology. 2021; 28(3):2123-2133.
https://doi.org/10.3390/curroncol28030197
Chicago/Turabian Style
Mandel, Philipp, Mike Wenzel, Benedikt Hoeh, Maria N. Welte, Felix Preisser, Tahir Inam, Clarissa Wittler, Clara Humke, Jens Köllermann, Peter Wild,
and et al. 2021. "Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making" Current Oncology 28, no. 3: 2123-2133.
https://doi.org/10.3390/curroncol28030197
APA Style
Mandel, P., Wenzel, M., Hoeh, B., Welte, M. N., Preisser, F., Inam, T., Wittler, C., Humke, C., Köllermann, J., Wild, P., Würnschimmel, C., Tilki, D., Graefen, M., Kluth, L. A., Karakiewicz, P. I., Chun, F. K.-H., & Becker, A.
(2021). Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making. Current Oncology, 28(3), 2123-2133.
https://doi.org/10.3390/curroncol28030197